Encapsulate Pharma
Pharmaceutical Manufacturing • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 3254 |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at Encapsulate Pharma
Jay Calder
Founder & Managing Director
Encapsulate Pharma Email Formats
Encapsulate Pharma uses 1 email format. The most common is {last name}{first initial} (e.g., doej@encapsulatepharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name}{first initial} | doej@encapsulatepharma.com | 100% |
About Encapsulate Pharma
Encapsulate Pharma is an Australian Pharmaceutical Company focused on the Marketing, Sales and Distribution of Speciality Pharmaceuticals. Encapsulate Pharma is the Official Partner of Merz Therapeutics, a fully owned subsidiary of Merz Pharmaceuticals, in delivering therapies for patients with Movement disorders and Spasticity in the Australian Market. We are committed to providing Physicians and their patients with high quality Botulinum Toxin manufactured by Merz Pharmaceuticals together with the support to deliver this treatment effectively to improve patient outcomes – helping patients achieve their goals.
Encapsulate Pharma revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Encapsulate Pharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Encapsulate Pharma has never raised funding before.
France
Italy
United Kingdom
United States
Frequently asked questions
4.8
40,000 users
